Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Wafergen To Locate First Foreign Plant In India

This article was originally published in PharmAsia News

Executive Summary

Wafergen Biosystems of California plans to locate its first foreign plant for producing stem cells in India. Wafergen CEO Alnoor Shivji said the deal means his company can use the plant to focus on activities at the pre-production stage of smart-chip development. The parent company plans to operate through its Malaysian subsidiary, Wafergen Biosystems Malaysia. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC066708

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel